A new HPLC analytical method for o-hydroxyhippuric acid in uremic serum.
o-Hydroxyhippuric acid (HHA) is formed in liver during the process of detoxication of salicylic acid which arises from either salicylic-containing dietary vegetables or hydrolysis of aspirin. Recently, HHA has also been shown as one of the so-called 'uremic toxins'. By derivatization of HHA with o-phthaldialdehyde (OPA), the resulting fluorescent product can easily be measured with the limit of measurement somewhere below 3 pmol on high performance liquid chromatography. Using the method described, an approximately 85% recovery of added HHA in human sera was obtained. This analytical system is now being employed to determine the concentration of HHA in human sera of uremic patients. Determination of HHA content in human uremic patients is very important, since uremia is associated with defective binding of many acidic drugs to serum protein(s) and HHA replaces these drugs by tightly binding to these proteins. This could potentially affect the therapeutic effectiveness of various pharmacologic agents.
D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D006626:Hippurates / Q000097:blood*; D006801:Humans; D013050:Spectrometry, Fluorescence; D014511:Uremia / Q000097:blood*; D009764:o-Phthalaldehyde
D006626:Hippurates; C000693:salicylurate; D009764:o-Phthalaldehyde